Delcath Systems Inc (DCTH)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Delcath Systems Inc (DCTH) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8013819
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Delcath Systems Inc (Delcath) is a specialty pharmaceutical and medical device company, which specializes in developing percutaneous perfusion technologies to treat primary and metastatic liver cancers. Its patented drug delivery platform delivers ultra-high doses of anti-cancer drugs to the liver, while preventing them from entering the patient’s bloodstream. Delcath’s proprietary product, Melphalan Hydrochloride for injection is being developed for use with the Delcath Hepatic Delivery System (Melphalan/HDS) and to administer high dose chemotherapy to the liver. The company sells its proprietary system to deliver and filter melphalan hydrochloride in Europe under the trade name, Delcath Hepatic Chemosat Delivery System for Melphalan (Chemosat). Delcath is headquartered in New York, the US.

Delcath Systems Inc (DCTH) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Delcath Systems Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Delcath Systems Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Delcath Systems Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Delcath Systems Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Delcath Systems Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Delcath Systems Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Delcath Systems Files Registration Statement for Public Offering of Units for USD17.3 Million 10
Delcath Systems to Raise USD2.4 Million in Private Placement of Series B Preferred Shares 11
Delcath Systems Raises USD1.3 Million in Public Offering Shares and Warrants 12
Delcath Systems Raises USD7 Million in Public Offering of Units 13
Delcath Systems Raises USD3 Million in Public Offering of Shares and Warrants 15
Delcath Systems to Raise Additional USD6 Million in Public Offering of Shares 17
Delcath Systems Completes Public Offering Of Shares For US$7.5 Million 18
Delcath Systems Completes Private Placement Of Shares For US$2 Million 19
Delcath Systems Completes Public Offering Of Units For US$23 Million 20
Delcath Systems Completes Second Tranche Of Private Placement Of Shares For US$1.2 Million 21
Delcath Systems Files Registration Statement For Public Offering Of Securities For US$100 Million 23
Delcath Systems Completes Public Offering Of Common Stock For US$25.3 Million 24
Delcath Systems Inc – Key Competitors 25
Delcath Systems Inc – Key Employees 26
Delcath Systems Inc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Financial Announcements 28
Nov 14, 2017: Delcath Announces Third Quarter 2017 Financial Results 28
Aug 08, 2017: Delcath Announces Second Quarter 2017 Financial Results 30
May 09, 2017: Delcath Announces First Quarter 2017 Financial Results 32
Mar 29, 2017: Delcath Announces 2016 Financial Results 34
Aug 16, 2016: Delcath Announces Second Quarter Financial Results 36
May 04, 2016: Delcath Announces First Quarter Financial Results 38
Mar 21, 2016: Delcath Announces 2015 Fourth Quarter and Full Year Financial Results 39
Corporate Communications 41
Feb 11, 2016: Delcath announces Engagement of Lars E. Birgerson, M.D., Ph. D as global medical consultant 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
Delcath Systems Inc, Medical Equipment, Key Facts, 2016 2
Delcath Systems Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Delcath Systems Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Delcath Systems Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Delcath Systems Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Delcath Systems Inc, Deals By Market, 2011 to YTD 2017 8
Delcath Systems Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Delcath Systems Files Registration Statement for Public Offering of Units for USD17.3 Million 10
Delcath Systems to Raise USD2.4 Million in Private Placement of Series B Preferred Shares 11
Delcath Systems Raises USD1.3 Million in Public Offering Shares and Warrants 12
Delcath Systems Raises USD7 Million in Public Offering of Units 13
Delcath Systems Raises USD3 Million in Public Offering of Shares and Warrants 15
Delcath Systems to Raise Additional USD6 Million in Public Offering of Shares 17
Delcath Systems Completes Public Offering Of Shares For US$7.5 Million 18
Delcath Systems Completes Private Placement Of Shares For US$2 Million 19
Delcath Systems Completes Public Offering Of Units For US$23 Million 20
Delcath Systems Completes Second Tranche Of Private Placement Of Shares For US$1.2 Million 21
Delcath Systems Files Registration Statement For Public Offering Of Securities For US$100 Million 23
Delcath Systems Completes Public Offering Of Common Stock For US$25.3 Million 24
Delcath Systems Inc, Key Competitors 25
Delcath Systems Inc, Key Employees 26
Delcath Systems Inc, Other Locations 27
Delcath Systems Inc, Subsidiaries 27

★海外企業調査レポート[Delcath Systems Inc (DCTH)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cancer Genetics Inc (CGIX):企業の財務・戦略的SWOT分析
    Summary Cancer Genetics Inc (CGI) is a pharmaceutical company that provides diagnostics products and services in oncology areas. The company offers products such as CGH microarrays, next-generation sequencing and DNA-FISH Probes. Its oncology tests and laboratory services offer critical genomic info …
  • Pier 1 Imports, Inc.:戦略・SWOT・企業財務分析
    Pier 1 Imports, Inc. - Strategy, SWOT and Corporate Finance Report Summary Pier 1 Imports, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Ewopharma AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Ewopharma AG (Ewopharma) is a pharmaceutical company that provides registration and marketing of pharmaceuticals and consumer health products. The company provides services such as market evaluation, marketing services, regulatory affairs, licensing, pharmacovigilance, and others. It offers …
  • Asian Hotels (North) Limited:企業の戦略・SWOT・財務情報
    Asian Hotels (North) Limited - Strategy, SWOT and Corporate Finance Report Summary Asian Hotels (North) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Strides Pharma Science Ltd (STAR):企業の財務・戦略的SWOT分析
    Summary Strides Pharma Science Ltd (Strides Pharma), formerly Strides Shasun Ltd, develops and manufactures finished dosage formulations and generic pharmaceutical products. The company operates through pharma, branded generic and institutional business segments. It manufactures soft and hard gelati …
  • Visteon Corporation:企業の戦略・SWOT・財務分析
    Visteon Corporation - Strategy, SWOT and Corporate Finance Report Summary Visteon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • IGas Energy PLC (IGAS):企業の財務・戦略的SWOT分析
    IGas Energy PLC (IGAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Kenya Power and Lighting Co Ltd (KPLA):企業の財務・戦略的SWOT分析
    Kenya Power and Lighting Co Ltd (KPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Sensus Healthcare Inc (SRTS):企業の財務・戦略的SWOT分析
    Sensus Healthcare Inc (SRTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Novartis Pharmaceuticals Corp-製薬・医療分野:企業M&A・提携分析
    Summary Novartis Pharmaceuticals Corp (Novartis), a subsidiary of Novartis AG is a developer, manufacturer and distributor of active ingredients, patent protected medicines and treatments for the healthcare industry. The company’s products include innovative prescription medicine and drugs, tablets, …
  • Rotork Plc (ROR):石油・ガス:M&Aディール及び事業提携情報
    Summary Rotork Plc (Rotork) is a manufacturer of actuator. The company’s key offerings include electric actuators, fluid power actuators, gearboxes, mounting kits and precision control instruments. The company also provides installation, maintenance and repair, field services, technical support and …
  • Forrester Research Inc (FORR):企業の財務・戦略的SWOT分析
    Summary Forrester Research Inc (Forrester) is a market research company that offers research and advisory services. The company offers services such as custom consulting, proprietary research, consumer and business data, worldwide events and peer executive programs. Forrester provides research for p …
  • Angelini Group:企業の戦略的SWOT分析
    Angelini Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Perpetual Limited (PPT):企業の財務・戦略的SWOT分析
    Perpetual Limited (PPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • PTT Exploration and Production Public Co Ltd (PTTEP):石油・ガス:M&Aディール及び事業提携情報
    Summary PTT Exploration and Production Public Company Limited (PTTEP), a subsidiary of PTT Public Company Limited, is an oil and gas company. It carries out exploration, development and production of hydrocarbons. The company manages an array of exploration projects in different stages and producing …
  • Superior Energy Services Inc (SPN):企業の財務・戦略的SWOT分析
    Superior Energy Services Inc (SPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Apache Corporation:戦略・SWOT・企業財務分析
    Apache Corporation - Strategy, SWOT and Corporate Finance Report Summary Apache Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • C.A. Curtze Co. Inc.
    C.A. Curtze Co. Inc. - Strategy, SWOT and Corporate Finance Report Summary C.A. Curtze Co. Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • C-Rad AB (CRAD B)-医療機器分野:企業M&A・提携分析
    Summary C-Rad AB (C-Rad) is a medical device company that develops, manufactures and markets advanced radiation therapy equipments. The company offers products and solutions for patient positioning, tumor localization, and radiation treatment systems. Its products include sentinel 4DCT, catalyst HD, …
  • Fanuc Corp (6954)
    Fanuc Corp (6954) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company

◆H&Iグローバルリサーチ株式会社のお客様(例)◆